Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment,…
Tag: COPD
GSK plc (GSK) Stock Rises as FDA Approves Nucala for COPD, CHMP Backs Blenrep for Cancer Treatment
GSK plc (NYSE:GSK) has strengthened its market outlook following major regulatory milestones. The U.S. FDA’s recent approval of Nucala for…